Gilead R&D chief Bischofberger to go back to his roots at startup Kronos

Longtime Gilead research vet Norbert Bischofberger has landed at the cancer drug discovery startup Kronos Bio as its new president and CEO. He stepped down in April as executive VP for R&D and chi…
Read the full story: FierceBiotech: Biotech